Cervical Cancer and the Role of Human Papillomavirus (HPV)
Keywords:
Cervical cancer, human papillomavirus, HPV infection, cervical screening, HPV DNA testing, cancer preventionAbstract
Cervical cancer remains a major health challenge for women around the world, particularly in low- and middle-income countries (LMICs). Persistent infections caused by high-risk types of the human papillomavirus (HPV) are recognized as the leading cause of cervical cancer. Understanding the epidemiological factors, diagnostic methods, and prevention strategies related to HPV is crucial for effective disease control. In this study, we aim to explore the role of HPV in the onset and progression of cervical cancer and evaluate the effectiveness of current screening and management strategies. Our objectives include examining the prevalence of high-risk HPV genotypes and their association with precancerous and cancerous cervical lesions, as well as assessing the value of HPV-based screening methods. We will use a mixed-methods approach that combines a systematic review of peer-reviewed literature with a thorough analysis of clinical and epidemiological data from cervical screening programs. We will also employ molecular diagnostic techniques, such as HPV DNA testing and cytological analysis, to evaluate detection accuracy and clinical outcomes. Our preliminary results indicate a strong link between chronic high-risk HPV infections and the development of invasive cervical cancer. HPV-based screening shows greater sensitivity than traditional cytology, highlighting the need for its broader implementation. This study is innovative in that it combines virology, clinical insights, and preventive strategies for cervical cancer into a unified analysis. The findings will have practical implications for cervical cancer prevention efforts.
References
1. J. Doorbar et al., “The biology and life-cycle of human papillomaviruses,” Nature Reviews Microbiology, vol. 20, no. 5, pp. 299–314, 2022.
2. P. S. Ojha, M. M. Maste, S. Tubachi, and V. S. Patil, “Human papillomavirus and cervical cancer: An insight highlighting pathogenesis and targeted strategies,” Journal of Cancer Research and Clinical Oncology, vol. 148, no. 10, pp. 2579–2592, 2022. https://doi.org/10.1007/s13337-022-00768-w
3. Marc Arbyn, Sara B Smith, Sarah Temin, Farhana Sultana, Philip Castle., “Detecting cervical precancer and reaching underscreened women by using HPV testing on self-samples: updated meta-analyses,” BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4823
4. L. Bruni, M. Diaz, L. Barrionuevo-Rosas, R. Herrero, F. Bray, F. X. Bosch, S. de Sanjosé, and X. Castellsagué, “Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis,” The Lancet Global Health, vol. 4, no. 7, pp. e453–e463, 2016, doi: 10.1016/S2214-109X(16)30099-7.
5. M. Schiffman and P. E. Castle, “The promise of global cervical cancer prevention,” New England Journal of Medicine, vol. 353, no. 20, pp. 2101–2104, Nov. 2005.
6. B. J. Lieblong, B. E. E. Montgomery, L. J. Su, and M. Nakagawa, “Natural history of human papillomavirus and vaccinations in men: A literature review,” Pathogens, vol. 8, no. 2, p. 80, 2019
7. R. Sankaranarayanan, B. M. Nene, S. S. Shastri, K. Jayant, R. Muwonge, A. M. Budukh, S. Hingmire, S. G. Malvi, R. Thorat, A. Kothari, R. Chinoy, R. Kelkar, S. Kane, S. Desai, V. R. Keskar, R. Rajeshwarkar, N. Panse, and K. A. Dinshaw, “HPV screening for cervical cancer in rural India,” New England Journal of Medicine, vol. 360, no. 14, pp. 1385–1394, 2009, doi: 10.1056/NEJMoa0808516.
8. N. Sritharan, N. Gnanavel, P. Inparaj, and D. Meedeniya, “Explainable artificial intelligence driven segmentation for cervical cancer screening,” IEEE Access, vol. 13, pp. 71306–71322, Apr. 2025, doi: 10.1109/ACCESS.2025.3561178.
9. H. A. Sarhangi, D. Beigifard, E. Farmani, and H. Bolhasani, “Deep learning techniques for cervical cancer diagnosis based on pathology and colposcopy images,” Informatics in Medicine Unlocked, vol. 47, p. 101503, 2024, doi: 10.1016/j.imu.2024.101503.
10. S. Mehammed, A. Yesuf, D. Getaneh, and M. N. Alam, “Systematic literature review: Machine learning approaches in cervical cancer prediction,” Preprints, Sep. 2025, doi:
10.20944/preprints202509.0205.v1
11. L. Wang et al., “HPV-based cervical cancer detection using hybrid CNN models,” in Proc. IEEE Int. Conf. Biomed. Eng., 2021.
12. P. Kaur et al., “Smart screening systems for HPV-related cervical cancer,” in Lect. Notes Comput. Sci., Springer, 2020, doi: 10.1007/978-3-030-60859-2_18.
13. World Health Organization, Global strategy to accelerate the elimination of cervical cancer, Geneva, Switzerland, 2020. [Online]. Available:
https://www.who.int/publications/i/item/9789240014107
14. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, vol. 119, Lyon, France, 2019. Available: https://monographs.iarc.who.int
15. E. J. Crosbie et al., “The evolving role of HPV testing in cervical cancer prevention,” Nat. Rev. Clin. Oncol., vol. 19, pp. 713–726, 2022
